AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25619686
Drug: Aloe cream
RxNorm normalized name: VIT A/VIT E/ALOE CREAM
DrugBank: Aloe ferox leaf (DB14257)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe cream
Trial: 18840368
Drug: Midodrine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midodrine (5 mg, oral)
Trial: 12580653
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g of HMB per day for 4 weeks
Trial: 10831205
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (1.0 mg for age > 60 yr; 1.5 mg for age ≤ 59 yr)
Trial: 2428219
Drug: Tiacrilast (Ro
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiacrilast (Ro 22-3747) 350 mg oral dose
Trial: 2428219
Drug: Cromoglycate 20
RxNorm normalized name: cromoglycate
DrugBank: Cromoglicic acid (DB01003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cromoglycate 20 mg by inhalation
Trial: 27861516
Drug: mCME intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: mCME intervention - Group 2 (passive model): daily SMS bullet point, required to reply to acknowledge receipt
Trial: 24508367
Drug: short-term psychotherapy
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: short-term psychotherapy (short-term psychodynamic or solution-focused)
Trial: 18591525
Drug: Sucrose (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose (2 mL of a 24% sucrose solution)
Trial: 12939564
Drug: nifedipine gastrointestinal
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: nifedipine gastrointestinal therapeutic system 30 mg
Trial: 8869092
Drug: Cisplatin 6
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 6 mg/m2 administered 1-2 hours before each radiation fraction, with escalating total doses during treatment.
Trial: 6238116
Drug: ICI 118630
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 118630 (Zoladex) 3.6 mg
Trial: 6238116
Drug: ICI 118630
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 118630 (Zoladex) 1.8 mg
Trial: 6238116
Drug: ICI 118630
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 118630 (Zoladex) 0.9 mg
Trial: 6238116
Drug: ICI 118630
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 118630 (Zoladex) (all doses)
Trial: 25339485
Drug: Spironolactone (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (20 mg/d) treatment group
Trial: 22866821
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus dipyridamole (A + D)
Trial: 22866821
Drug: Aspirin only
RxNorm normalized name: Aspirin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin only (A)
Trial: 19931382
Drug: 2+1-dose schedule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2+1-dose schedule
Trial: 19931382
Drug: 3+1-dose schedule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3+1-dose schedule
Trial: 15705360
Drug: Riluzole (50-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riluzole (50-200 mg/day)
Trial: 15705360
Drug: Lithium (open
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium (open treatment for a minimum of 4 weeks)
Trial: 11917239
Drug: Cyclosporin-A (CsA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin-A (CsA) 2 mg/kg twice daily for 12 weeks
Trial: 9457004
Drug: Self-administered physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered physical activity frequency questionnaire (PAFQ)
Trial: 2220725
Drug: Sucralfate suspension
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralfate suspension (1 g/10 ml) plus cimetidine (300 mg qid)
Trial: 31633789
Drug: Lower-dose venlafaxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower-dose venlafaxine (≤150 mg/d)
Trial: 25707477
Drug: NNC0109‐0012 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NNC0109‐0012 (3 mg/kg per week, subcutaneously)
Trial: 23388003
Drug: Rivaroxaban, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban, 10 mg once daily for 35±4 days
Trial: 23388003
Drug: Enoxaparin, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin, 40 mg once daily for 10±4 days followed by placebo
Trial: 21163281
Drug: Caffeine (CAF)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (CAF) 3 mg kg(‐1) ingested 60 min before and 45 min after exercise in 33°C
Trial: 19474135
Drug: 60 g
RxNorm normalized name: aspirin 60 Grains
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 g low-TFA lipids/d (0.54 g/d; n = 21)
Trial: 19474135
Drug: Ruminant TFA-rich
RxNorm normalized name: Maltose-rich malted barley extract
DrugBank: Barley malt syrup (DB14601)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ruminant TFA-rich lipids (4.86 g/d; n = 21)
Trial: 19474135
Drug: Industrial TFA-rich
RxNorm normalized name: Maltose-rich malted barley extract
DrugBank: Barley malt syrup (DB14601)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Industrial TFA-rich lipids (5.58 g/d; n = 21)
Trial: 15209643
Drug: Galantamine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine at a maintenance dose of 16 or 24 mg/d
Trial: 11575284
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg of ADL 8‐2698
Trial: 11575284
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of ADL 8‐2698
Trial: 9783800
Drug: Thiotepa (TTP)
RxNorm normalized name: Thiotepa
DrugBank: Thiotepa (DB04572)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Thiotepa (TTP) 5 mg/kg x 2 days (days -4, -3) along with busulfan (BU) 4 mg/kg x 4 days and cyclophosphamide (CY) 60 mg/kg x 2 days
Trial: 7868872
Drug: Parathyroid hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Parathyroid hormone levels
Trial: 2908008
Drug: Urapidil 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil 15 mg intravenously
Trial: 2908008
Drug: Urapidil 30
RxNorm normalized name: urapidil 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil 30 mg intravenously
Trial: 2908008
Drug: Urapidil (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil (both doses)
Trial: 31704549
Drug: Vemurafenib 960
RxNorm normalized name: Vemurafenib
DrugBank: Vemurafenib (DB08881)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vemurafenib 960 mg twice daily for 52 weeks
Trial: 28566525
Drug: RRR-alpha-tocopherol (40.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RRR-alpha-tocopherol (40.2 mg)
Trial: 28566525
Drug: MIX (22.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MIX (22.8 mg all-rac-alpha-tocopherol acetate + 20.1 mg RRR-alpha-tocopherol)
Trial: 28566525
Drug: ARAC (45.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARAC (45.5 mg all-rac-alpha-tocopherol acetate)
Trial: 24750558
Drug: Tapentadol PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol PR 300 mg/day
Trial: 24750558
Drug: Tapentadol PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol PR 500 mg/day
Trial: 24750558
Drug: Tapentadol PR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol PR 300 mg/day plus pregabalin 300 mg/day
Trial: 9562314
Drug: Collar therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collar therapy for 6 weeks
Trial: 9562314
Drug: Collar therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collar therapy for 12 weeks
Trial: 9562314
Drug: Collar therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collar therapy
Trial: 8179463
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral treatment (CBT) including breathing retraining, muscle relaxation, cognitive reframing, and exposure to interoceptive and agoraphobic stimuli for 12 sessions.
Trial: 8179463
Drug: Nonprescriptive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonprescriptive treatment (reflective listening) for 12 sessions.
Trial: 2888638
Drug: Ranitidine 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 250 mg hs for four days prior to chloroquine administration
Trial: 2888638
Drug: Chloroquine sulfate
RxNorm normalized name: Chloroquine sulfate
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine sulfate (300‐mg base) only
Trial: 29630101
Drug: CT-guided implantation
RxNorm normalized name: brompheniramine tannate Chewable Tablet [BroveX CT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT-guided implantation of 125I seeds in combination with chemotherapy
Trial: 27158849
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral therapy for adherence and depression (CBT‐AD)
Trial: 24047799
Drug: Rotarix™ vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotarix™ vaccine
Trial: 19861187
Drug: Aerosolized Triviraten
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosolized Triviraten vaccine (including Rubini mumps strain)
Trial: 19861187
Drug: Aerosolized Edmonston-Zagreb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized Edmonston-Zagreb (EZ) measles vaccine
Trial: 19861187
Drug: Injected Moraten
RxNorm normalized name: morantel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injected Moraten measles vaccine (twice the dosage)
Trial: 19861187
Drug: Aerosolized mumps
RxNorm normalized name: mumps virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized mumps vaccine (Leningrad-Zagreb strain)
Trial: 9833911
Drug: Prednisone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (30 mg per day initially, tapered to 10 mg daily after 8 weeks) and azathioprine (50 mg daily)
Trial: 7978715
Drug: Clarithromycin 1000
RxNorm normalized name: clarithromycin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 1000 mg twice daily
Trial: 7978715
Drug: Clarithromycin 2000
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin 2000 mg twice daily
Trial: 2688237
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream (lidocaine/prilocaine)
Trial: 999302
Drug: Fluorouracil and
RxNorm normalized name: Fluorouracil and salicylic acid only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluorouracil and 0.5% triamcinolone acetonide cream
Trial: 999302
Drug: Diluted (0.1%)
RxNorm normalized name: phenol
DrugBank: Phenol (DB03255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diluted (0.1%) triamcinolone acetonide cream
Trial: 31692152
Drug: Plasma CRP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma CRP ≥2.0 mg/l
Trial: 26059332
Drug: Selumetinib 75
RxNorm normalized name: Sélumétinib
DrugBank: Selumetinib (DB11689)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selumetinib 75 mg twice daily in combination with dacarbazine 1000 mg/m² on Day 1 of every 21-day cycle
Trial: 26059332
Drug: Dacarbazine 1000
RxNorm normalized name: Dacarbazine
DrugBank: Dacarbazine (DB00851)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dacarbazine 1000 mg/m²
Trial: 9832976
Drug: Levodopa (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa (100 mg) and benserazide (25 mg)
Trial: 8508870
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose intravenous antibiotic prophylaxis (4 g piperacillin and 800 mg tinidazole 30 minutes before surgery)
Trial: 8508870
Drug: Multiple dose
RxNorm normalized name: Rebetron, multiple dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple dose intravenous antibiotic prophylaxis (4 g piperacillin 30 minutes before surgery, 4 g piperacillin 8 hours after, and 4 g piperacillin and 800 mg tinidazole 16 hours after the first dose)
Trial: 29436896
Drug: Routine health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine health education delivered monthly by community nurses (Control)
Trial: 23345601
Drug: 300 mg/day
RxNorm normalized name: alpelisib 300 mg/day (150 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/day avocado-soybean unsaponifiable (ASU-E)
Trial: 21568147
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy (Group A): omeprazole, amoxicillin, metronidazole, and bismuth, twice daily for 2 weeks
Trial: 21568147
Drug: Ciprofloxacin based
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin based triple therapy (Group C): omeprazole and amoxicillin, twice daily for 2 weeks, and ciprofloxacin twice a day for the first week
Trial: 21568147
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy (Group D): omeprazole, amoxicillin for 5 days, followed by omeprazole, clarithromycin, and metronidazole for the remaining 5 days, all twice daily for 10 days
Trial: 21568147
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Group B): omeprazole, amoxicillin, and clarithromycin, twice daily for 10 days
Trial: 18082484
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment after fibrinolysis
Trial: 14966633
Drug: Doxycycline slow-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline slow-release gel
Trial: 11113239
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g Cr/day for 4 weeks
Trial: 8232134
Drug: Flurbiprofen mouth
RxNorm normalized name: Flurbiprofen
DrugBank: Flurbiprofen (DB00712)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flurbiprofen mouth wash 10 ml, 3 times daily for 7 days
Trial: 8232134
Drug: Placebo mouth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo mouth wash 10 ml, 3 times daily for 7 days
Trial: 25415695
Drug: 100 kV
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 100 kV with 90 mL iopromide 370 mg I/mL at 3.5 mL/s
Trial: 23017784
Drug: Cola (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cola (1 liter daily)
Trial: 23017784
Drug: Deionized water
RxNorm normalized name: WATER,DEIONIZED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deionized water (1 liter daily)
Trial: 20415698
Drug: Bosentan (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bosentan (250 mg)
Trial: 9931532
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment (1 mg/m2/d)
Trial: 7772643
Drug: Metyrapone 750
RxNorm normalized name: Metyrapone
DrugBank: Metyrapone (DB01011)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metyrapone 750 mg followed by oCRF 0.3 microgram/kg
Trial: 1969869
Drug: Procaterol 25
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procaterol 25 micrograms escalating to 100 micrograms, and 100 micrograms twice daily
Trial: 1969869
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose of procaterol
Trial: 375050
Drug: Alice/R‐75 2-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alice/R‐75 2-dose vaccine
Trial: 375050
Drug: Alice/R‐75 1-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alice/R‐75 1-dose vaccine
Trial: 375050
Drug: Placebo 2-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 2-dose
Trial: 375050
Drug: Alice strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alice strain monovalent influenza A vaccine
Trial: 375050
Drug: R‐75 strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R‐75 strain monovalent vaccine
Trial: 19387173
Drug: Continuous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous insulin infusion (target glucose 100-150 mg/dl)
Trial: 19387173
Drug: Standard intermittent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intermittent insulin bolus (treat glucose > 150 mg/dl)
Trial: 19387173
Drug: Standard intermittent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard intermittent insulin bolus
Trial: 11128858
Drug: GAKIC (glycine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GAKIC (glycine and L-arginine salt of alpha-ketoisocaproic acid calcium)
Trial: 1487885
Drug: Nitrogranulong 5.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrogranulong 5.2 mg
Trial: 1487885
Drug: Nitrogranulong 10.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrogranulong 10.4 mg
Trial: 1487885
Drug: Trinitrolong 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trinitrolong 2 mg
Trial: 1487885
Drug: Nitrong 6.5
RxNorm normalized name: Nitrong 6.5 MG Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrong 6.5 mg
Trial: 25623589
Drug: Antibiotic (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic (oral sultamicillin) for five days
Trial: 16621446
Drug: Acetyl-L-carnitine administration
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine administration
Trial: 15641866
Drug: No antidepressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antidepressant medication (control group)
Trial: 15641866
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg mirtazapine (for treatment after diagnosis)
Trial: 9573545
Drug: L-arginine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine infusion (30 g)
Trial: 9573545
Drug: Control infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control infusion (30 g branched chain amino acids)
Trial: 3400679
Drug: Cefoperazone 2
RxNorm normalized name: cefoperazone 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoperazone 2 g intravenously every 12 hours and mezlocillin 4 g intravenously every six hours
Trial: 3400679
Drug: Imipenem/cilastatin 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem/cilastatin 500 mg intravenously over 30 to 60 minutes every six hours
Trial: 27544829
Drug: Cognitive-behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavior therapy for insomnia (CBTi)
Trial: 29499675
Drug: internet-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: internet-delivered cognitive behavioural therapy (iCBT) for 8 weeks duration with regular post-session feedback by Psychological Wellbeing Practitioners
Trial: 25697860
Drug: CET plus
RxNorm normalized name: Cocet Plus
DrugBank: Codeine (DB00318)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CET plus D-cycloserine (50 mg)
Trial: 19655818
Drug: Cardioselective beta-adrenoceptor
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardioselective beta-adrenoceptor antagonists (CSB); 212 patients (51% of 412 evaluable patients) were taking CSB.
Trial: 16754416
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg atomoxetine QD
Trial: 16754416
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg atomoxetine BID
Trial: 16754416
Drug: Both QD
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both QD and BID treatments
Trial: 15317833
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg fenofibrate
Trial: 26286133
Drug: 50 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mL 4.2% sodium bicarbonate
Trial: 26286133
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL 4.2% sodium bicarbonate
Trial: 26286133
Drug: 50 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mL 2.1% sodium bicarbonate
Trial: 23447103
Drug: Peaceful Mind
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peaceful Mind cognitive-behavioral therapy for anxiety in persons with dementia; details on dosage and duration not specified.
Trial: 11601037
Drug: Sevoflurane in
RxNorm normalized name: sevoflurane Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sevoflurane in oxygen without any other drugs (Control Group)
Trial: 7776391
Drug: syrup with
RxNorm normalized name: Sambucus Elderberry Nighttime Syrup with Melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: syrup with a 10-ml measuring cup
Trial: 7776391
Drug: syrup with
RxNorm normalized name: Sambucus Elderberry Nighttime Syrup with Melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: syrup with a 5-ml measuring spoon